Correction: Maturation of the Intestinal Epithelial Barrier in Neonatal Rats Coincides with Decreased FcRn Expression, Replacement of Vacuolated Enterocytes and Changed Blimp-1 Expression.

Correction: Maturation of the Intestinal Epithelial Barrier in Neonatal Rats Coincides with Decreased FcRn Expression, Replacement of Vacuolated Enterocytes and Changed Blimp-1 Expression.

[This corrects the article DOI: 10.1371/journal.pone.0164775.].

Bibliographic Details
Main Authors:	Ester Arévalo Sureda, Björn Weström, Stefan G Pierzynowski, Olena Prykhodko
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5207483?pdf=render

Similar Items

Maturation of the Intestinal Epithelial Barrier in Neonatal Rats Coincides with Decreased FcRn Expression, Replacement of Vacuolated Enterocytes and Changed Blimp-1 Expression.
by: Ester Arévalo Sureda, et al.
Published: (2016-01-01)

Abundant intracellular IgG in enterocytes and endoderm lacking FcRn.
by: Sudhasri Mohanty, et al.
Published: (2013-01-01)

Identification of Four Mouse FcRn Splice Variants and FcRn-Specific Vesicles
by: George Haddad, et al.
Published: (2024-03-01)

Characterization of the rabbit neonatal Fc receptor (FcRn) and analyzing the immunophenotype of the transgenic rabbits that overexpresses FcRn.
by: Ana Paula Catunda Lemos, et al.
Published: (2012-01-01)

The role of FcRn in antigen presentation
by: Kristi eBaker, et al.
Published: (2014-08-01)

The Neonatal Fc Receptor (FcRn): A Misnomer?
by: Michal Pyzik, et al.
Published: (2019-07-01)

FcRn Expression in Endometrial Cancer and Its Association with Clinicopathologic Features
by: Dae Hyun Song, et al.
Published: (2023-12-01)

Human FcRn Tissue Expression Profile and Half-Life in PBMCs
by: Yao-Yun Fan, et al.
Published: (2019-08-01)

FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues
by: Tommy Li, et al.
Published: (2018-10-01)

Roles of FcRn in Antigen-Presenting Cells during Autoimmunity and a Clinical Evaluation of Efgartigimod as an FcRn Blocker
by: Yihan Zhou, et al.
Published: (2023-06-01)

In Translation: FcRn across the Therapeutic Spectrum
by: Timothy Qi, et al.
Published: (2021-03-01)

Megalin Orchestrates FcRn Endocytosis and Trafficking
by: Eileen Dahlke, et al.
Published: (2022-12-01)

Selection of bispecific antibodies with optimal developability using FcRn‑pH‑HPLC as an optimized FcRn affinity chromatography method
by: Thomas Müller, et al.
Published: (2023-12-01)

FcRN receptor antagonists in the management of myasthenia gravis
by: Vinaya Bhandari, et al.
Published: (2023-08-01)

The importance of FcRn in neuro-immunotherapies: From IgG catabolism, gene polymorphisms, IVIg dosing and efficiency to specific FcRn inhibitors
by: Marinos C. Dalakas, et al.
Published: (2021-02-01)

FcRn Overexpression Expands Diversity of the Humoral Immune Response in bFcRn Transgenic Mice
by: Bence Szikora, et al.
Published: (2020-08-01)

Human IgE does not bind to human FcRn
by: Maximilian Brinkhaus, et al.
Published: (2022-01-01)

Cell surface dynamics and cellular distribution of endogenous FcRn.
by: Lena D'Hooghe, et al.
Published: (2017-01-01)

Zika Virus Infection and Antibody Neutralization in FcRn Expressing Placenta and Engineered Cell Lines
by: Yanqun Xu, et al.
Published: (2022-11-01)

Pancreatic and pancreatic-like microbial proteases accelerate gut maturation in neonatal rats.
by: Olena Prykhodko, et al.
Published: (2015-01-01)

Human FcRn expression and Type I Interferon signaling control Echovirus 11 pathogenesis in mice.
by: Alexandra I Wells, et al.
Published: (2021-01-01)

Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods
by: Christophe Dumet, et al.
Published: (2023-03-01)

The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement
by: Maximilian Brinkhaus, et al.
Published: (2022-10-01)

FcRn as a Transporter for Nasal Delivery of Biologics: A Systematic Review
by: Maxime Fieux, et al.
Published: (2021-06-01)

Trafficking analyses of FcRn and IgG ligand in the post-Brambell era
by: E. Sally eWard, et al.
Published: (2015-07-01)

FcRn mediated IgG transport by retinal pigment epithelium cells
by: Korthagen Nicoline M, et al.
Published: (2012-11-01)

Algorithmic multiscale analysis for the FcRn mediated regulation of antibody PK in human
by: Dimitris G. Patsatzis, et al.
Published: (2022-04-01)

Characterization of the interactions of rabbit neonatal Fc receptor (FcRn) with rabbit and human IgG isotypes.
by: Bence Szikora, et al.
Published: (2017-01-01)

Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review
by: Yanis Ramdani, et al.
Published: (2022-08-01)

Efgartigimod, an FcRn antagonist, as a potential treatment for post COVID-19 syndrome
by: Sandra E. Reznik, et al.
Published: (2023-06-01)

Human FcRn Is a Two-in-One Attachment-Uncoating Receptor for Echovirus 18
by: Xiangpeng Chen, et al.
Published: (2022-08-01)

Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment
by: Diana Cadena Castaneda, et al.
Published: (2018-09-01)

Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy
by: Christopher R. Wilcox, et al.
Published: (2017-10-01)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
by: Takuo Suzuki, et al.
Published: (2021-01-01)

Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro
by: Omar S. Qureshi, et al.
Published: (2024-12-01)

Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models
by: Delphine Valente, et al.
Published: (2020-01-01)

FcRn regulates antigen presentation in dendritic cells downstream of DEC205-targeted vaccines
by: Christophe Macri, et al.
Published: (2024-04-01)

Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia
by: Trang T. Vu, et al.
Published: (2024-01-01)

Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrier
by: Jason Tien, et al.
Published: (2023-12-01)

An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission
by: Weizhong Li, et al.
Published: (2023-11-01)